Literature DB >> 9602425

Influence of pHi and creatine phosphate on alpha-adrenoceptor-mediated cardiac hypertrophy.

K D Schlüter1, M Schäfer, C Balser, G Taimor, H M Piper.   

Abstract

Stimulation of alpha-adrenoceptors on ventricular cardiomyocytes isolated from adult rat hearts leads to cellular alkalization, increases of creatine phosphate concentration, RNA mass, and protein synthesis. This study investigated whether the increase of creatine phosphate concentrations is causally linked to the hypertrophic response of cardiomyocytes under alpha-adrenoceptor stimulation. Cellular alkalization achieved with phenylephrine (10 microM), an alpha-adrenoceptor agonist, was abolished in the presence of the sodium-proton-exchange (NHE)-inhibitor HOE 694 (1 microM). HOE 694 inhibited also the alpha-adrenoceptor-mediated increase in cellular creatine phosphate and the increase in cellular RNA mass. The phenylephrine-induced stimulation of protein synthesis (determined by incorporation of 14C-phenylalanine) was reduced by one-third when HOE 694 was present. beta-Guanidinopropionic acid was added to cardiomyocytes to reduce cellular creatine phosphate concentrations. In these cultures, alpha-adrenoceptor stimulation activated NHE, but creatine phosphate concentrations were not increased. Protein synthesis was augmented to the same extent as in control cultures, but total RNA mass did not increase. From these results we conclude that alpha-adrenoceptor stimulation causes the increase in protein synthesis via activation of NHE, but independent of the concomitant increase in creatine phosphate contents. The effect of alpha-adrenoceptor stimulation on total RNA mass (translational capacity) is also caused by NHE activation, but depends on the changes in creatine phosphate contents as well.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9602425     DOI: 10.1006/jmcc.1998.0640

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  6 in total

Review 1.  Regulation of cardiac sarcolemmal Na+/H+ exchanger activity: potential pathophysiological significance of endogenous mediators and oxidant stress.

Authors:  M Avkiran; A K Snabaitis
Journal:  J Thromb Thrombolysis       Date:  1999-07       Impact factor: 2.300

Review 2.  Alterations of sodium-hydrogen exchanger 1 function in response to SGLT2 inhibitors: what is the evidence?

Authors:  Surasak Wichaiyo; Nakkawee Saengklub
Journal:  Heart Fail Rev       Date:  2022-02-18       Impact factor: 4.654

Review 3.  NHE-1 inhibition: from protection during acute ischaemia/reperfusion to prevention/reversal of myocardial remodelling.

Authors:  Wolfgang J Linz; Andreas E Busch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-19       Impact factor: 3.000

4.  Inhibition of Na+/H+-exchanger with sabiporide attenuates the downregulation and uncoupling of the myocardial beta-adrenoceptor system in failing rabbit hearts.

Authors:  Kirsten Leineweber; Stephanie Aker; Anja Beilfuss; Heike Rekasi; Ina Konietzka; Claus Martin; Gerd Heusch; Rainer Schulz
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

5.  Role of the 5'-untranslated region in regulating translational efficiency of specific mRNAs in adult cardiocytes.

Authors:  Laura S Spruill; Paul J McDermott
Journal:  FASEB J       Date:  2009-05-05       Impact factor: 5.191

Review 6.  The effect of the creatine analogue beta-guanidinopropionic acid on energy metabolism: a systematic review.

Authors:  Inge Oudman; Joseph F Clark; Lizzy M Brewster
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.